Dorfmüller G, Fohlen M, Bulteau C, Delalande O
Service de neurochirurgie, unité de neurochirurgie pédiatrique, fondation ophtalmologique A-de-Rothschild, 25-29 rue Manin, 75940 Paris cedex 19, France.
Neurochirurgie. 2008 May;54(3):315-9. doi: 10.1016/j.neuchi.2008.02.043. Epub 2008 May 2.
Surgical resection of hypothalamic hamartomas (HHs) associated with drug-resistant gelastic epilepsy carries a considerable risk of neurological and endocrine morbidity. Alternative surgical routes and techniques have therefore been proposed, especially for broadly attached lesions and for those with a third ventricular location.
We present an updated series of 43 patients (aged nine months to 34 years), operated on from 1998 through 2005 at our institution. The hamartoma was disconnected using a microsurgical pterional approach of those lesions extending from the hypothalamic floor downward into the interpeduncular cistern. When the HH presented as a paramedian mass, partly or exclusively bulging into the third ventricle, with a rather vertical plane of attachment, we chose a frameless stereotactic endoscopic technique to disconnect the lesion. In several of our patients, both methods were applied subsequently.
Surgery-related morbidity was lower with the ventricular endoscopic technique. Twenty-one patients (50%) are seizure-free and two patients (5%) almost seizure-free, while in 17 patients (40%), there was a significant seizure reduction. Two patients (5%) had no postoperative improvement. According to the different topographic features of the HHs, for which we have recently proposed a classification into four subtypes, the intraventricularly located hamartoma had the best prognosis following endoscopic disconnection. Ten of the 12 patients (83%) with this HH location became seizure-free.
Resection of epilepsy-related HHs can be replaced by disconnective procedures. Our results confirm their feasibility and acceptable morbidity, with particularly good seizure outcome in patients with intraventricularly located HHs.
手术切除与耐药性痴笑性癫痫相关的下丘脑错构瘤(HHs)会带来相当大的神经和内分泌发病风险。因此,人们提出了替代手术途径和技术,特别是对于广泛附着的病变以及位于第三脑室的病变。
我们报告了1998年至2005年在我们机构接受手术的43例患者(年龄从9个月至34岁)的最新系列病例。对于那些从下丘脑底部向下延伸至脚间池的病变,采用显微手术翼点入路切断错构瘤。当HH表现为中线旁肿块,部分或完全突入第三脑室,且附着平面较为垂直时,我们选择无框架立体定向内镜技术切断病变。在我们的一些患者中,随后应用了这两种方法。
脑室内镜技术的手术相关发病率较低。21例患者(50%)无癫痫发作,2例患者(5%)几乎无癫痫发作,而17例患者(40%)癫痫发作显著减少。2例患者(5%)术后无改善。根据HHs的不同地形特征,我们最近将其分为四个亚型,其中位于脑室内的错构瘤在内镜切断术后预后最佳。12例该部位HH患者中有10例(83%)无癫痫发作。
与癫痫相关的HHs的切除可以被切断手术所替代。我们的结果证实了其可行性和可接受的发病率,对于位于脑室内的HH患者,癫痫发作结果尤其良好。